Fritextsökning
Innehållstyper
-
Unga bolag får Vinnova-pengar
Tre life science-bolag finns med på listan med nystartade bolag som får finansiering från Vinnova.
-
Lena Björk lämnar ledningsgruppen
Nu har hela ledningsgruppen på Läkemedelsverket bytts ut sedan Christina Åkerman tillträdde som generaldirektör för fem år sedan.
-
Första patienten transplanterad
Den första njurtransplantationen har nu utförts i en klinisk studie med Hansa Medicals läkemedelskandidat Ides.
-
Prenatal testing breakthrough
For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.
-
Norwegian describes scrapie gene
Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.
-
Första Crispr-bolaget till börsen
Editas Medicine blir det första bolaget på börsen med fokus på det omtalade genmodifieringsverktyget Crispr/Cas9.
-
Top modern lab to Sahlgrenska
The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.
-
Abbott expands by acquisition
An acquisition gives Abbott a leadership position in another large and growing medical device segment.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Bio-Linux goes global
Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.
-
BMAs: Run your own business
After graduation you must decide: be an employee or start your own business. This is not really the situation for BMAs today, but a collaborative project betwee...
-
Lund sökte mest statliga medel
Totalt 112 ansökningar om statliga medel för strategisk forskning har inkommit. Populärast är vårdforskning medan cancerforskning endast fått tre ansökningar.
-
Danisco first with green emulsifier
A new sustainable emulsifier from Danisco meets the increasing consumer demand for ethically correct consumer goods.
-
Happy exhibitors!
There were fewer vistors this year but most exhibitors are content.
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
-
Isconova köper vaccinbolag
Utökar med dansk adjuvansteknik och vaccinplåster.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Astrazeneca i unikt samarbete
Astrazeneca, Göteborgs universitet och Chalmers meddelar i dag att man ingått ett nytt unikt samarbete. - Vi har byggt om våra lokaler för att kunna hysa instru...
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.
-
Immunicum levererar till USA
Förser amerikansk institution med adenovirusvektor för Crispr/Cas9-tekniken.
-
Siemens och Raysearch gör slut
Medicinteknikbolagen Raysearch laboratories och Siemens Healthcare har beslutat att avsluta sitt samarbete.